Take a look behind the scenes of a recent Future Microbiology review, entitled ‘Could targeting neighboring bacterial populations help to combat bacterial vaginosis?’, as we ask the authors about the challenges in treating bacterial vaginosis (BV) and the future of this field.
Based on the demonstrated potential of laser-induced vapor nanobubbles to treat bacterial biofilm infections, we provide recommendations for future work in order to further mature this new technology into a promising anti-biofilm approach.
New research from the Stevens Institute of Technology has developed a microgel coating for implanted medical devices that can release micro-doses of antibiotics on bacterial contact, potentially combatting infection.
In this interview with Trisha Peel from Monash University, she explains the issues surrounding device-related infections in addition to discussing some promising new approaches to diagnosis and treatment.
Researchers from the Okinawa Institute of Science and Technology have developed a method to study biofilm formation, and how it is affected by drugs, with high efficacy.
The Microbe Directory is a collective research effort aiming to profile over 7,000 microbes in order to provide further information for any researchers carrying out metagenomic analyses. We spoke to two of the Project Leaders, Heba Shaaban and David Westfall about the project, how it’s being used in research and how you can get involved.
Investigating heat-shock gene htpG and the production of virulence factors in Pseudomonas aeruginosa
This study, recently published in Future Microbiology, aimed to study the effects of encoded heat-shock protein 90 homolog (htpG) on the selected virulence factors responsible for pathogenesis and biofilm formation of P. aeruginosa.
For the first time, researchers have employed an electroceutical technique – using electric field-based dressings – to manage biofilm infections. Understanding how this technique could influence host–microbe interactions will be pivotal in its application to wound healing in humans.
A novel CRISPR–Cas9-based gene drive platform has been developed by researchers and may help us understand some of the genetic networks underlying virulence in fungal pathogen, Candida albicans.
While sepsis is well defined clinically, the molecular immunological mechanisms that underlie the development of sepsis are poorly understood.